Judge Stands By $21M Jury Verdict In Sulindac Case

Law360, New York (January 7, 2011, 5:41 PM EST) -- A federal judge has shot down Mutual Pharmaceutical Co.'s attempt to overturn a jury award of $21 million to a woman who was blinded and suffered a near-fatal skin disease after taking the generic-drug company's anti-inflammatory drug Sulindac.

Judge Joseph Laplante of the U.S. District Court for the District of New Hampshire on Wednesday dismissed Mutual's motion for a new trial and motion for judgment as a matter of law, ruling that the damages were substantial but acceptable in light of the severe injuries plaintiff Karen...
To view the full article, register now.